These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Omadacycline: A Novel Oral and Intravenous Aminomethylcycline Antibiotic Agent. Zhanel GG; Esquivel J; Zelenitsky S; Lawrence CK; Adam HJ; Golden A; Hink R; Berry L; Schweizer F; Zhanel MA; Bay D; Lagacé-Wiens PRS; Walkty AJ; Lynch JP; Karlowsky JA Drugs; 2020 Feb; 80(3):285-313. PubMed ID: 31970713 [TBL] [Abstract][Full Text] [Related]
24. Omadacycline and Garey KW; Rose W; Gunter K; Serio AW; Wilcox MH Ann Pharmacother; 2023 Feb; 57(2):184-192. PubMed ID: 35656828 [TBL] [Abstract][Full Text] [Related]
25. In vitro activity of omadacycline against pathogens isolated from Mainland China during 2017-2018. Dong D; Zheng Y; Chen Q; Guo Y; Yang Y; Wu S; Zhu D; Deng D; Bradford PA; Reinhart H; Hu F Eur J Clin Microbiol Infect Dis; 2020 Aug; 39(8):1559-1572. PubMed ID: 32356026 [TBL] [Abstract][Full Text] [Related]
26. Antimicrobial activity of LFF571 and three treatment agents against Clostridium difficile isolates collected for a pan-European survey in 2008: clinical and therapeutic implications. Debast SB; Bauer MP; Sanders IM; Wilcox MH; Kuijper EJ; J Antimicrob Chemother; 2013 Jun; 68(6):1305-11. PubMed ID: 23420839 [TBL] [Abstract][Full Text] [Related]
27. [In Vitro Activities of Antimicrobials Against Toxigenic Clostridioides difficile Isolates Obtained in a University Training and Research Hospital in Turkey]. Sayın E; Bilgin H; Söyletir G; Ülger Toprak N Mikrobiyol Bul; 2020 Jul; 54(3):368-377. PubMed ID: 32755514 [TBL] [Abstract][Full Text] [Related]
28. In vitro activity of new tetracycline analogues omadacycline and eravacycline against clinical isolates of Helicobacter pylori collected in China. Yang Y; Bian L; Hang X; Yan C; Huang Y; Ye F; Zhang G; Jin G; Bi H Diagn Microbiol Infect Dis; 2020 Nov; 98(3):115129. PubMed ID: 32739761 [TBL] [Abstract][Full Text] [Related]
29. Activities of Omadacycline and Comparator Agents against Staphylococcus aureus Isolates from a Surveillance Program Conducted in North America and Europe. Pfaller MA; Rhomberg PR; Huband MD; Flamm RK Antimicrob Agents Chemother; 2017 Mar; 61(3):. PubMed ID: 27993854 [TBL] [Abstract][Full Text] [Related]
30. Fecal Pharmacokinetics and Gut Microbiome Effects of Oral Omadacycline Versus Vancomycin in Healthy Volunteers. Jo J; Hu C; Begum K; Wang W; Le TM; Agyapong S; Hanson BM; Ayele H; Lancaster C; Jahangir Alam M; Gonzales-Luna AJ; Garey KW J Infect Dis; 2024 Jan; 229(1):273-281. PubMed ID: 38051631 [TBL] [Abstract][Full Text] [Related]
31. Minimal inhibitory concentration of omadacycline and doxycycline against bacterial isolates with known tetracycline resistance determinants. Fluit AC; van Gorkum S; Vlooswijk J Diagn Microbiol Infect Dis; 2019 May; 94(1):78-80. PubMed ID: 30583881 [TBL] [Abstract][Full Text] [Related]
32. Evaluation of the antimicrobial activity of ridinilazole and six comparators against Chinese, Japanese and South Korean strains of Clostridioides difficile. Collins DA; Wu Y; Tateda K; Kim HJ; Vickers RJ; Riley TV J Antimicrob Chemother; 2021 Mar; 76(4):967-972. PubMed ID: 33351917 [TBL] [Abstract][Full Text] [Related]
33. Antimicrobial susceptibilities of Clostridium difficile isolated in Japan. Kunishima H; Chiba J; Saito M; Honda Y; Kaku M J Infect Chemother; 2013 Apr; 19(2):360-2. PubMed ID: 23338015 [TBL] [Abstract][Full Text] [Related]
34. High Prevalence of Multidrug-Resistant Mutai WC; Mureithi MW; Anzala O; Revathi G; Kullin B; Burugu M; Kyany'a C; Odoyo E; Otieno P; Musila L Front Cell Infect Microbiol; 2020; 10():604986. PubMed ID: 33628744 [TBL] [Abstract][Full Text] [Related]
37. Evaluation of the in vitro activity of levornidazole, its metabolites and comparators against clinical anaerobic bacteria. Hu J; Zhang J; Wu S; Zhu D; Huang H; Chen Y; Yang Y; Zhang Y Int J Antimicrob Agents; 2014 Dec; 44(6):514-9. PubMed ID: 25301712 [TBL] [Abstract][Full Text] [Related]
38. Sun X; Zhang B; Xu G; Chen J; Shang Y; Lin Z; Yu Z; Zheng J; Bai B Ann Lab Med; 2021 May; 41(3):293-301. PubMed ID: 33303714 [TBL] [Abstract][Full Text] [Related]
39. In vitro activity of linezolid against Clostridium difficile. Peláez T; Alonso R; Pérez C; Alcalá L; Cuevas O; Bouza E Antimicrob Agents Chemother; 2002 May; 46(5):1617-8. PubMed ID: 11959617 [TBL] [Abstract][Full Text] [Related]
40. U.S.-Based National Surveillance for Fidaxomicin Susceptibility of Clostridioides difficile-Associated Diarrheal Isolates from 2013 to 2016. Thorpe CM; McDermott LA; Tran MK; Chang J; Jenkins SG; Goldstein EJC; Patel R; Forbes BA; Johnson S; Gerding DN; Snydman DR Antimicrob Agents Chemother; 2019 Jul; 63(7):. PubMed ID: 31085514 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]